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Constraint-induced movement therapy (CIMT) has gained considerable popularity as a treatment technique for upper extremity
rehabilitation among patients with mild-to-moderate stroke. While substantial evidence has emerged to support its applicability,
issues remain unanswered regarding the best and most practical approach. Following the establishment of what can be called
the “signature” CIMT approach characterized by intense clinic/laboratory-based practice, several distributed forms of training,
collectively known as modiﬁed constraint therapy (mCIMT), have emerged. There is a need to examine the strengths and
limitations of such approaches, and based upon such information, develop the components of a study that would compare the
signatureapproachtothebestelementsofmCIMT,referredtohereas“alternative”CIMT.BaseduponaPEDroreviewofliterature,
limitations in mCIMT studies for meeting criteria were identiﬁed and discussed. A suggestion for a “ﬁrst eﬀort” at a comparative
study that would both address such limitations while taking practical considerations into account is provided.
1.Introduction
Recent advances in stroke rehabilitation research, including
constraint-induced movement therapy (CIMT), have the
potential to change traditional therapeutic approaches in
clinicalpractice.However,communicatingbestpracticesand
implementing change remain signiﬁcant challenges for both
researchers and practicing clinicians to overcome. In a recent
Canadian study, Menon et al. [1] found that, despite the
evidence of best practice in stroke rehabilitation, the imple-
mentation of best practice in the clinic was inconsistent and
underutilized, as clinicians continued to apply traditional
neurodevelopmental techniques in the treatment of individ-
uals after stroke. Barriers to incorporating evidence-based
practice (EBP) into clinical settings are well documented and
fallundertwogeneralcategories:individualclinicianbarriers
and organization barriers [1–3]. Lack of time and resources
is often cited by clinicians as primary limitations to reading
orsearchingtheliterature[1–3]asw ellasself-eﬃcacy.Inthis
context,self-eﬃcacymeansthedegreetowhichanindividual
clinician feels capable of searching, reading, analyzing, and
implementing evidence-based practice into her daily clinical
practice and thought processing. Low self-eﬃcacy may
be more prevalent in clinicians who have been working
for 15 or more years because of lack of formal education
in EBP skills [1, 2]. Organizational barriers can include
lackofcomputersoraccesstoresearchdatabases,theabsence
of active research in clinical settings and limited encourage-
ment of professional development, with a growing emphasis
on productivity [1, 2]. The combination of time constraints,
productivity pressures, volume of research available, and
a dearth in EBP skills may, over time, create an even
greater gap between best evidence and current practice [1].
National and international guidelines for evidence-based
practice following stroke can assist clinicians in determining
bestpracticebycompilingrecentadvancesinstrokeresearch.
Theseguidelinesareeasilyaccessibleanddecreasetheburden
on clinicians to search and assess the literature themselves.
However, they may not always provide suﬃcient evidence
or information regarding a particular intervention, and
there may not be a shared consensus among guidelines.2 Stroke Research and Treatment
In the case of constraint-induced movement therapy,
drawing a solid conclusion after reviewing prominent stroke
guidelines is diﬃcult. For instance, in a scientiﬁc statement
from the American Heart Association [4], CIMT is recom-
mended for chronic stroke patients with greater than 10
degrees ﬁnger extension, but no parameters of treatment are
provided. Australian stroke guidelines paint a less conclusive
picture of CIMT, concluding that CIMT is eﬀective with
more than 20 hours of training, but possibly detrimental
when provided very early in the rehabilitation process [5].
Here again no treatment parameters were oﬀered for the
delivery of CIMT and the lack of methodological consistency
in the literature was noted. New Zealand guidelines brieﬂy
mention CIMT as a possible rehabilitation approach, but
make no recommendations regarding patient criteria or
the parameters to deliver CIMT [6]. Canadian guidelines,
updated in 2010, oﬀer the most speciﬁc details for patient
criteria and protocol parameters for signature or modiﬁed
CIMT (mCIMT) in early stroke rehabilitation [7]. These
diﬀerences yield a lack of clarity regarding recommendations
for CIMT and may in part be precipitated by the lack of
methodological quality in the modiﬁed CIMT literature.
The purpose of this paper is therefore multi-fold: (1)
present current perspectives of signature CIMT and the
evolution of mCIMT; (2) discuss limitations in current
CIMT literature by using PEDro criteria as a basis to; (3)
suggest an “alternative” form of modiﬁed CIMT, which can
subsequently be compared to the signature form in a “head-
to-head”comparison,ﬁrstinpreliminarystudiesandthenas
a formal clinical trial. This consideration is important since
such an eﬀort has not been formally undertaken.
1.1. Current Perspectives of Signature CIMT and the Evolution
of mCIMT. Constraint-induced movement therapy (CIMT)
isawidelyexploredtreatmentprotocoltoincreasefunctional
use of the more impaired upper extremity (UE) for persons
with hemiparetic stroke. The theoretical basis for CIMT was
developed through early research in nonhuman primates
from which the concept of learned nonuse following limb
somatosensory deaﬀerentation emerged [8, 9]. Taub and
colleagues described the learned nonuse phenomenon as a
behavioural adaptation that occurs in response to the loss
of sensory feedback due to a decrease in coordinated move-
ments, negative reinforcement from unsuccessful attempts
with the impaired limb, and positive reinforcement resulting
from success in compensatory movement patterns with the
unimpaired limb. The result of this sequelae is a decrease
in functional use of the impaired UE [10]. This undesirable
adaptation was overcome in monkeys by restraining the
insensate limb, thus forcing them to use the impaired UE
[11].
According to Taub and colleagues [12], learned nonuse
occurring after somatosensory deaﬀerentation in nonhuman
primatesiscomparabletothatseenfollowingcentralnervous
system (CNS) insult in humans, such as after stroke. In
the ﬁrst application of a treatment technique to overcome
learned nonuse in humans, a patient with hemiparetic
stroke was asked to perform functional tasks with the
more impaired UE with restraint of the less aﬀected UE
[13]. Restraint, in addition to encouraging without formally
trainingmassedpracticeoftheimpairedUE,resultedinwhat
Wolf et al. called “forced use” [14].
The protocol has evolved to speciﬁcally include repet-
itive and adaptive task practice under clinical supervision.
These additional structured elements collectively deﬁne the
current concept of CIMT. Repetitive task practice (RTP) is
continuous blocked practice of a speciﬁc functional task,
usually for a period of 15–20 minutes. Adaptive task practice
(ATP), or shaping, uses a step-wise approximation method,
breaking down tasks into successive manageable compo-
nents to improve overall proﬁciency [15, 16]. Based upon
the underlying operant conditioning through provision of
therapist feedback, shaping fosters patient problem solving,
resulting in self-motivation to use the aﬀected limb [16].
This intensive practice fosters motor relearning and has
been shown to promote neural plasticity in the CNS [15].
Successful application of CIMT is thought to induce a use-
dependent increase in cortical reorganization of the areas of
the brain controlling the most aﬀected limb [17, 18].
Severalstudies,primarilyinmildtomoderatelyimpaired
survivors of stroke, have demonstrated clinically relevant
results [12, 19–21]. However, limitations, such as small
sample sizes within trials, variations in time since stroke,
andalternativeCIMTprotocols,weakenedtheabilitytodraw
signiﬁcant conclusions about pertinent ﬁndings [22, 23]. In
2006, results from the ﬁrst Phase III, multisite, randomized
clinical study, the EXtremity Constraint-Induced Therapy
Evaluation (EXCITE) trial, were published and showed sta-
tistically and clinically relevant conﬁrmation of the eﬃcacy
of CIMT in patients three-to-nine months posthemiparetic
stroke [24].
Signature CIMT, developed by Taub [12, 25] and later
used in the EXCITE [24] trial, included restraint of the less
impaired upper extremity by donning a protective safety
mitt for 90% of waking hours over a two-week intervention
period. Subjects were also required to participate in six
hours/day (ﬁve days/week) of ATP and RTP [10, 24]. Some
researchers have criticized this signature protocol as being
impractical in clinical settings [26–31]. Patient tolerance,
mitt wearing adherence, feasibility in clinics, and reimburse-
ment issues have been emphasized as key weaknesses of the
signature CIMT protocol, thus potentially acting as barriers
to more pervasive clinical implementation [32, 33].
In response to these critiques, a number of “modiﬁed”
versions have arisen to address the issues presented by
the signature form of CIMT. Some investigators altered
intensity protocols by distributing total treatment time over
a longer duration. For example, Wu et al. [29, 34, 35]
decreased the intensity to two hours/day (ﬁve days/week) but
increased duration to three weeks, which required only six
hours/dayofupperextremityrestraint.Pageetal.[26,33,36]
increased treatment duration to 10 weeks, with 30 minutes
of intervention per day, three days/week and reduced mitt
restraint to ﬁve hours/day. Other investigators expanded
the inclusion criterion for relative chronicity. Ro et al. [37]
included subjects 14 days after stroke, and Miltner et al.
[38] included subjects up to 17 years after stroke. While all
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improving motor function, these studies, like early signature
CIMT research, are also limited by small sample sizes. Of all
trials included in previous reviews of CIMT, only two studies
had greater than 30 participants [22, 23].
Despite signiﬁcant variability in protocols, each form
of treatment delivery claims the name “modiﬁed” CIMT
[35, 39]. The issue therein is the lack of standardization by
whichtoestablishaconsistentreferencepointformonitoring
treatment dosage, creating confusion among the researcher,
therapist and reimbursement communities. Therefore, an
analysis of existing modiﬁed CIMT protocols, to devise
a reasonable synthesis of approaches called “alternative”
CIMT, should be performed and becomes a necessary
precursor before a best model alternative intervention that
incorporates key elements, such as intensity, duration, and
subject chronicity [40, 41], can be constructed. This best
model alternative protocol can then be formally compared to
signature CIMT to determine if an alternative, more feasible
approach is equally eﬀective.
An important ﬁrst step, intended to increase the veracity
of these future studies, is the analysis of the methodological
quality of current CIMT literature using a valid and reliable
tool to determine worthy inclusion in development of the
alternative treatment protocol. To build a strong study at any
level, including only the highest quality literature as a foun-
dation for study design and in support of ﬁndings, becomes
a critical consideration. Not only do these factors increase
the integrity of any immediate study, but also that of future
studies. Unlike previous reviews which explored only CIMT
eﬃcacy [22, 23], we sought to critically analyze existing
CIMT methodologies in order to systematically determine
speciﬁc deﬁciencies within articles. Worthy articles can then
be selected for use in determining an alternative form CIMT,
which can then compared to the signature form in a “head-
to-head” comparison.
The evaluation tool chosen for analyzing methodological
quality of CIMT research was the Physiotherapy Evidence
Database (PEDro). PEDro applies 11 criteria, 10 of which
are scored (see Appendix A)t oa s s i g naq u a n t i t a t i v em e a s u r e
of study strength [42]. This particular set of criteria was
chosen for its speciﬁcity to physical therapy literature; use by
novice and expert researchers alike; reliability [43]; strength
in assessing methodological quality speciﬁcally in stroke
literature [44].
Although the authors did not intend to perform a
systematic review of the CIMT literature, several articles
were selected from 1998–2008 as a comprehensive sampling
to use as the basis for this discussion. The list of CIMT liter-
ature was compiled using the following electronic databases:
PubMed,CochraneLibrary,MEDLINE,andOvid.Keyterms
included constraint-induced movement therapy, modiﬁed
CIMT, hemiparetic stroke, and constraint-induced therapy.
Approximately 75 studies were deemed relevant for
further review, based upon title and abstract containing
CIMT or “modiﬁed” CIMT. Studies were excluded if all
three components of CIMT (ATP, RTP, and restraint) were
not administered in at least one group; they contained
paediatricparticipants(<18yearsofage),usedsubjectsother
than patients with stroke, were systematic reviews/meta-
analyses, or were nonexperimental literature (case studies,
letters to the editor, or perspectives). Experimental literature
accepted for use in this review included Sackett’s levels
of evidence: 1b, 2b, and 3b (see Appendix B)[ 45]. After
employing this procedure, 27 articles, published between
1999 and 2008, were chosen for inclusion in this discussion
[24, 26–31, 33, 34, 37, 38, 46–61].
Therapist raters with comparable experience in research
design, independently rated each of 27 CIMT articles using
PEDro criteria. A series of detailed discussions regarding
the nature and interpretation of these criteria preceded the
actual rating exercise. All raters were blinded to each other’s
assessments. A “yes” was given for each criterion the rater
believed was satisﬁed by the article. Total scores reﬂected
the total number of “yes” answers given on eligible criteria
(2–11 are considered “eligible” for scoring). One reviewer
compiled the results of the three raters. Scores were not
discussed among raters prior to compilation or statistical
analysis. A post-hoc analysis showed that raters could not
agree upon whether some studies met three particular
PEDro criteria: baseline similarity between groups, outcome
measures obtained for at least 85% of participants, and
clarity regarding successfully meeting the “intention to treat”
directive (see Appendix A).
There may be several explanations for interrater discrep-
ancies. Lack of clarity in some PEDro operational deﬁnitions
may have contributed to varying interpretations among
reviewers. Hence there may have been some uncertainty
about whether studies clearly articulated and implemented
an intention to treat strategy. A discussion amongst raters
suggested that disagreement between raters may have been
precipitated by alternative interpretations or poorly deﬁned
aspects of methodologies or outcomes. Such misinterpre-
tations could be overcome through clearer precision in
the delineation of methods. For criterion four (baseline
similarity), some articles calculated signiﬁcant diﬀerences
between groups for only a few characteristics, but claimed
overall “baseline similarity.” This discrepancy in approach
left the reader unsure if the criterion was completely fulﬁlled.
Raters were commonly uncertain if outcomes measures were
collected in at least 85% of subjects (criteria eight). Finally,
report of attrition (criteria nine) was another source of
reader confusion due to unclear documentation. Subject
dropout had to be inferred in some cases from tables, rather
than explicitly stated in the text.
Additionally, raters agreed that blinding of evaluators
to subject allocation and intervention received were not
adequately addressed in the current review. Collectively,
these methodological weaknesses present a challenge for
clinicians to conﬁdently interpret and apply the principles of
thesealternativeformsofCIMT.Thesediscrepanciesbecame
the basis for the selection of elements that needed greater
clariﬁcation and inclusion in an alternative form of CIMT
against which one can then undertake a comparison with the
signature CIMT.
1.2. Eﬀorts to Create a Standardized Alternative Form of
CIMT. A recent article attempted to compare a version4 Stroke Research and Treatment
of modiﬁed CIMT to signature CIMT. Barzel and col-
leagues [62] compared signature CIMT to a 4-week home-
based modiﬁed CIMT program (CIMThome). CIMThome
patients and a family member received an initial day of
training from a physiotherapist regarding the two primary
components of signature CIMT: shaping and constraint of
the nonaﬀected upper extremity. CIMThome patients and
their caregivers then performed a self-managed program
at home for four weeks, with weekly visits by the phys-
iotherapist to supervise and advance therapeutic exercises
as appropriate. Despite the home-based program, patients
still received nearly 15 hours of supervision from a phys-
iotherapist. Results showed CIMThome to be as eﬀective
as signature CIMT; however, the sample size was small
with just seven chronic stroke patients in the CIMThome
group.
Hosomi and colleagues also developed a self-training
protocol using elements of signature CIMT [63]. Forty
patients were recruited based on signature CIMT criteria.
Patients were then instructed in a self-training protocol that
included instruction in shaping tasks to address individual
limitations. The protocol consisted of 20 minutes of self-
training per shaping task, culminating in 10–15 diﬀerent
training tasks per day (ﬁve hours a day for 10 consecutive
weekdays). Direct supervision by a physiotherapist occurred
every 20 minutes to evaluate patient performance and
advance therapeutic exercise as appropriate. Results showed
signiﬁcant improvements on the Fugl-Meyer Assessment,
the Wolf Motor Function Test, and The Motricity Index.
However, a major limitation of this study was having no
comparison to a control group or other modiﬁed CIMT pro-
tocol. Therefore, the weaknesses of methodology discussed
in this paper have still not been addressed in recent studies
either, and a need exists to generate a best-model alterna-
tive CIMT option that incorporates weaknesses extracted
from the literature.
1.3. Implications. In designing future studies, methodologies
must be clearly deﬁned and controlled to improve clarity for
readers and replication for clinical researchers. Speciﬁcally,
discrepancies were noted for attrition and diﬀusion of
intervention, and report of baseline statistics.
To provide evidence-based practice, increased numbers
of therapists are accessing and reading clinical trials in order
to choose appropriate interventions. When attempting to
qualify an article’s strength, clinicians and researchers may
use a system like PEDro. Therapists may be assumed to
use high- rather than low-scoring articles when choosing
interventions. However, if criterion satisfaction is unclear,
interpretation is left to the reader, leading to discrepancies in
perception of the value of a clinical trial that can ultimately
impactclinicianinterestinutilizationoftreatmentprotocols.
Am o r ea p p r o p r i a t ec o u r s eo fa c t i o nw o u l db et op l a c e
responsibility upon researchers to give greater attention to
clarity when describing methodological considerations.
Recently, within the ﬁeld of neurorehabilitation, there
has been a call to improve the value of studies [64, 65].
Dobkin [65] proposed performing a thorough qualitative
assessment of current literature as a key to accomplishing
a more systematic approach to method design, to increase
the integrity of multisite randomized clinical trials for motor
interventions. In the case of CIMT, we have performed
a comprehensive literature search and assessed the method-
ological quality of several articles to determine speciﬁc
deﬁciencies within the articles.
Secondarily, the most substantial elements that might
serve as the foundation of a “best model” alternative CIMT
protocol can also be proposed. Three articles in our mCIMT
review scored 8/10 on the PEDro scale [29, 31, 34], the
highest scores in our review. The frequency and intensity
of the modiﬁed CIMT interventions were very similar
across these studies: 2h/d, 5d/wk for 3wk. This treatment
intensity may be more feasible and practical than signature
CIMT. In addition, we propose further elements drawn
from signature CIMT, including two hours of home task
practice for three days per week for three weeks including
speciﬁcation and rationalization for this practice. Partici-
pants in this alternative form of CIMT would also undergo
30 minutes of a nonspeciﬁc but documented functional
activity six days per week and wear the restraining device
90% of waking hours. This dosing approximates 75 hours
over a three-week interval using a distributed practice
model that would be comparable to almost 80 hours (up
to six hours per day, ﬁve days per week for two weeks
in a clinic/laboratory environment in addition to about
two hours per day for 10 days of home-based activities)
ofsignatureCIMT.Forbothinterventions, restrictionofbet-
ter limb use would occur for 90% of waking hours through-
out the intervention period. Inclusion criteria would match
that established for the EXCITE Trial [24]. The alternative
CIMT plan would include therapist guided on-sight training
for two hours the ﬁrst day of each of three weeks with home
based assignment of mutually agreed tasks throughout the
remainder of the week for each of three weeks. Participants
in both groups would be evaluated before and after the
intervention with subsequent followups at 3 and 6 months
after intervention. The evaluator would be blinded to group
and the selected outcome measure would be standardized.
Dropouts would have last values carried forward (impu-
tation), a typical procedure in intention to treat studies.
The study would be powered based upon the selected
outcome measure. For example, if the outcome was the
WMFT, a reasonable change could be a 30 percent reduction
in median time to complete tasks associated with a patient
impression of percent improvement in function as suggested
by Fritz et al. [53]. Collectively, such a comparison would
address several issues. All the limitations observed in
the present PEDro review would be overcome, dose
equivalency would be established, a reasonable home based,
patient driven program could be standardized and compli-
ance measured, and immediate and intermediate end points
would optimize diﬃculties often encountered in tracking
participantsoveralongerperiodoftime.Afuturepilotstudy
will assess the feasibility and eﬃcacy of this proposed “best
model” alternative CIMT protocol to signature CIMT with
the intent to develop a signature mCIMT protocol.Stroke Research and Treatment 5
2. Possible Limitations
The exclusion of meta-analyses and case-studies presents a
possible limitation to the extensiveness of the PEDro review.
The PEDro system used in this review pertained only to
single clinical trials. Moreover, while there were only 27
articles comprising this review, such a number is relatively
high compared to previous systematic CIMT reviews. Three
existing systematic reviews in CIMT research, conducted
by Hakkennes and keating [22], Bonaiuti et al. [23], and
Corbetta et al. [66], included 14, nine, and 18 studies
respectively, and each review used only two reviewers. In the
Hakkenes and Keating [22] and Bonaiuti et al. [23]r e v i e w s
disagreements were discussed until scores were agreed
upon. Unlike these studies, disagreements between raters
in this study were viewed as valuable, and utilized to note
limitations in current research methods in hopes that the
design of future studies might address these considerations.
In addition, the Corbetta review [66] described a majority
of the articles chosen as “underpowered and imprecise,”
making the case for a larger RCT and underscoring the weak
methodology of the CIMT literature.
3. Conclusion
The model proposed in this paper is not only useful for
analysis of CIMT literature, but may serve as a template for
future studies in any genre of scientiﬁc inquiry. The quality
of CIMT literature, speciﬁcally modiﬁed and signature
methods, was examined closely in an attempt to increase the
integrity of a future pilot study comparing a “best model”
alternative CIMT protocol with the signature form of CIMT.
A direct comparison approach that addressed limitations
in the literature extracted from the PEDro review was sug-
gested. Eﬀorts by researchers to improve methodology and
standardization of protocols can greatly assist the practicing
clinician in analyzing EBP and incorporating best practices
into clinical practice. Establishing a standardized best-model
alternativeCIMTprotocolwouldalsoallowstrokeguidelines




(1) Eligibility criteria were speciﬁed.
(2) Subjects were randomly allocated to groups (in a
crossover study, subjects were randomly allocated an
order in which treatments were received).
(3) Allocation was concealed.
(4) The groups were similar at baseline regarding the
most important prognostic indicators.
(5) There was blinding of all subjects.
(6) Therewasblindingofalltherapistswhoadministered
the therapy.
(7) There was blinding of all assessors who measured at
least one key outcome.
(8) Measures of at least one key outcome were obtained
from more than 85% of the subjects.
(9) All subjects for whom outcome measures were avail-
able received the treatment or control condition as
allocated or, where this was not the case, data for at
least one key outcome was analyzed by “intention to
treat.”
(10) The results of between-group statistical comparisons
are reported for at least one key outcome.
(11) The study provides both point measures and mea-
sures of variability for at least one key outcome [42].
B .S ac k et t ’ sL ev el so fE vid e n c e
Levels of evidence for interventions [67]:
(1a) systematic reviews of randomized controlled trials
(RCTs),
(1b) individual RCTs with narrow conﬁdence interval,
(2a) systematic reviews of cohort studies,
(2b) individual cohort studies and low-quality RCTs,
(3a) systematic reviews of case-control studies,
(3b) case-controlled studies,
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